Brain metastases in HER2-positive breast cancer

被引：8
作者：
Lin, Nancy U. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Div Womens Canc, Boston, MA 02215 USA
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 03期
关键词：
NERVOUS-SYSTEM METASTASES; TRASTUZUMAB; LAPATINIB; WOMEN;
D O I：
10.1016/S1470-2045(13)70046-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：185 / 186
页数：3
相关论文
共 50 条
  • [1] Brain Metastases in HER2-Positive Breast Cancer: Current and Novel Treatment Strategies
    Garcia-Alvarez, Alejandro
    Papakonstantinou, Andri
    Oliveira, Mafalda
    CANCERS, 2021, 13 (12)
  • [2] Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
    Tomasello, Gianluca
    Bedard, Philippe L.
    de Azambuja, Evandro
    Lossignol, Dominique
    Devriendt, Daniel
    Piccart-Gebhart, Martine J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 75 (02) : 110 - 121
  • [3] Current treatment options for HER2-positive breast cancer patients with brain metastases
    Galanti, Daniele
    Inno, Alessandro
    La Vecchia, Maria
    Borsellino, Nicolo
    Incorvaia, Lorena
    Russo, Antonio
    Gori, Stefania
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 161
  • [4] Treatment of brain metastases of HER2-positive breast cancer
    Heudel, P.
    Tredan, O.
    Cassier, P.
    Ray-Coquard, I.
    Guastalla, J. -P.
    Bachelot, T.
    ONCOLOGIE, 2012, 14 (01) : 41 - 44
  • [5] Brain metastases from HER2-positive breast cancer
    Nieder, Carsten
    LANCET ONCOLOGY, 2013, 14 (01) : E2 - E3
  • [6] Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
    Yap, Y. S.
    Cornelio, G. H.
    Devi, B. C. R.
    Khorprasert, C.
    Kim, S. B.
    Kim, T. Y.
    Lee, S. C.
    Park, Y. H.
    Sohn, J. H.
    Sutandyo, N.
    Wong, D. W. Y.
    Kobayashi, M.
    Landis, S. H.
    Yeoh, E. M.
    Moon, H.
    Ro, J.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1075 - 1082
  • [7] Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer
    Duchnowska, Renata
    Loibl, Sibylle
    Jassem, Jacek
    CANCER TREATMENT REVIEWS, 2018, 67 : 71 - 77
  • [8] Prevention strategies for brain metastases from HER2-positive breast cancer
    Le Tourneau, Christophe
    BULLETIN DU CANCER, 2011, 98 (04) : 445 - 449
  • [9] Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
    Metro, G.
    Foglietta, J.
    Russillo, M.
    Stocchi, L.
    Vidiri, A.
    Giannarelli, D.
    Crino, L.
    Papaldo, P.
    Mottolese, M.
    Cognetti, F.
    Fabi, A.
    Gori, S.
    ANNALS OF ONCOLOGY, 2011, 22 (03) : 625 - 630
  • [10] Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab
    Kaplan, Muhammet Ali
    Ertugrul, Hamza
    Firat, Ugur
    Kucukoner, Mehmet
    Inal, Ali
    Urakci, Zuhat
    Pekkolay, Zafer
    Isikdogan, Abdurrahman
    BREAST CANCER, 2015, 22 (05) : 503 - 509
12345